From: Network-based cancer genomic data integration for pattern discovery
Module | Enriched GO/KEGG pathways | P-value |
---|---|---|
1 | GO:0006952˜defense response | 3.08e-12 |
1 | GO:0001775˜cell activation | 1.11e-10 |
1 | GO:0045321˜leukocyte activation | 2.55e-10 |
1 | GO:0006955˜immune response | 7.34e-10 |
1 | GO:0042110˜T cell activation | 1.42e-07 |
2 | GO:0006955˜immune response | 4.03e-12 |
2 | GO:0006414˜translational elongation | 1.28e-08 |
2 | hsa03010:Ribosome | 2.96e-08 |
2 | hsa04662:B cell receptor signaling pathway | 4.31e-08 |
2 | GO:0001775˜cell activation | 2.00e-07 |
3 | GO:0006414˜translational elongation | 2.11e-86 |
3 | hsa03010:Ribosome | 3.28e-81 |
3 | GO:0006412˜translation | 6.62e-57 |
3 | GO:0042273˜ribosomal large subunit biogenesis | 3.27e-04 |
3 | GO:0042254˜ribosome biogenesis | 2.38e-03 |
4 | GO:0006836˜neurotransmitter transport | 8.83e-06 |
4 | GO:0030182˜neuron differentiation | 3.50e-03 |
4 | GO:0007269˜neurotransmitter secretion | 6.71e-03 |
4 | GO:0050767˜regulation of neurogenesis | 1.79e-02 |
4 | GO:0048667˜cell morphogenesis involved in neuron diff. | 1.83e-02 |
6 | GO:0042110˜T cell activation | 8.05e-11 |
6 | hsa04660:T cell receptor signaling pathway | 3.35e-09 |
6 | GO:0045321˜leukocyte activation | 1.08e-08 |
6 | GO:0001775˜cell activation | 1.43e-08 |
6 | GO:0046649˜lymphocyte activation | 2.44e-08 |
7 | GO:0051276˜chromosome organization | 3.86e-10 |
7 | GO:0006350˜transcription | 7.90e-10 |
7 | GO:0006325˜chromatin organization | 1.98e-09 |
7 | GO:0045449˜regulation of transcription | 4.23e-08 |
7 | GO:0008380˜RNA splicing | 1.88e-07 |
9 | hsa04080:Neuroactive ligand-receptor interaction | 1.03e-04 |
10 | GO:0006955˜immune response | 1.61e-23 |
10 | hsa05330:Allograft rejection | 7.40e-16 |
10 | hsa04940:Type I diabetes mellitus | 5.44e-15 |
10 | hsa05332:Graft-versus-host disease | 1.46e-12 |
10 | hsa04672:Intestinal immune network for IgA production | 3.05e-11 |